Detailansicht

Wissensnetz

Person

Jack Hirsh (1935-)

Arzt

Name	Jack Hirsh
Zeit	1935- (Lebensdaten)
Ort	Lodz (Geburtsort) Melbourne (Geburtsort) Kanada
Akademischer Grad bzw. Titel	Prof.
Beruf	Arzt (charakteristischer Beruf) Hämostaseologe Hochschullehrer
Variante	Jack Hirsch J. Hirsh
Beziehung	McMaster University
Weitere Angaben	Geburtsdaten widersprüchlich ausgewiesen: 7. Januar 1935 in Łódź, Polen oder 5. Januar 1935 in Melbourne, Australien Professor Emeritus, Department of Medicine at McMaster University in Hamilton, Ontario
Quelle	LCAuth
Datensatztyp	Person
GND-Nummer	172139228
Datensatz-ID	172139228
Beteiligt an alle anzeigen Clinical Studies with Anticoagulants that Have Changed Clinical Practice Plasma Rivaroxaban Level to Identify Patients at Risk of Drug Overexposure: Is a Single Measurement of Drug Level Reliable? Reduction in Mortality following Elective Major Hip and Knee Surgery: A Systematic Review and Meta-Analysis Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets The development and validation of an instrument to measure the quality of health research reports in the lay media Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS) : A randomized controlled trial Lack of consistency in the relationship between asymptomatic DVT detected by venography and symptomatic VTE in thromboprophylaxis trials New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions Mandatory contrast-enhanced venography to detect deep-vein thrombosis (DVT) in studies of DVT prophylaxis: upsides and downsides Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction? Mechanism of Action and Monitoring of Anticoagulants Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer Low Molecular Weight Heparins (LMWH) in the Treatment of Patients with Acute Venous Thromboembolism Ventilation-Perfusion Lung Scanning and the Diagnosis of Pulmonary Embolism: Improvement of Observer Agreement by the Use of a Lung Segment Reference Chart Akuter Herzinfarkt : Thrombolyse und Begleittherapie ; Prinzipien und Praxis ; [Beilage zu "The lancet", deutsche Ausgabe, April 1992] Risks to the Fetus of Anticoagulant Therapy During Pregnancy Risks to the Fetus of Radiologic Procedures Used in the Diagnosis of Maternal Venous Thromboembolic Disease Platelets, drugs and thrombosis : proceedings of a symposium held at McMaster Univ., Hamilton, Ont., Oct. 16 - 18, 1972; [mit] 61 tables

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Jack Hirsh (1935-)

Clinical Studies with Anticoagulants that Have Changed Clinical Practice

Plasma Rivaroxaban Level to Identify Patients at Risk of Drug Overexposure: Is a Single Measurement of Drug Level Reliable?

Reduction in Mortality following Elective Major Hip and Knee Surgery: A Systematic Review and Meta-Analysis

Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada

In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets

The development and validation of an instrument to measure the quality of health research reports in the lay media

Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS) : A randomized controlled trial

Lack of consistency in the relationship between asymptomatic DVT detected by venography and symptomatic VTE in thromboprophylaxis trials

New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions

Mandatory contrast-enhanced venography to detect deep-vein thrombosis (DVT) in studies of DVT prophylaxis: upsides and downsides

Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?

Mechanism of Action and Monitoring of Anticoagulants

Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study

Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer

Low Molecular Weight Heparins (LMWH) in the Treatment of Patients with Acute Venous Thromboembolism

Ventilation-Perfusion Lung Scanning and the Diagnosis of Pulmonary Embolism: Improvement of Observer Agreement by the Use of a Lung Segment Reference Chart

Akuter Herzinfarkt : Thrombolyse und Begleittherapie ; Prinzipien und Praxis ; [Beilage zu "The lancet", deutsche Ausgabe, April 1992]

Risks to the Fetus of Anticoagulant Therapy During Pregnancy

Risks to the Fetus of Radiologic Procedures Used in the Diagnosis of Maternal Venous Thromboembolic Disease

Platelets, drugs and thrombosis : proceedings of a symposium held at McMaster Univ., Hamilton, Ont., Oct. 16 - 18, 1972; [mit] 61 tables